The dataset including clinico-pathological characteristics of 119 IA-IIIA NSCLC patients. Expression of mRNA of tested biomarkers (CEA, EGFR, LUNX, EpCAM, c-met) in peripheral blood (PB), bone marrow
The clinical characteristics and outcomes of younger versus older patients with EGFR-mutated advanced NSCLC undergoing first-line EGFR-TKI treatment remain underexplored. This multicenter, retrospecti
Technological advancements in the Non-Small Cell Lung Cancer industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transform
